RxDoctor Payments Data

Alan Gertler

Cardiovascular Disease · Birmingham, ALNPI 1548211618

Payments from drug & device makers

$2,407in general payments, 2019–2025

Across 139 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$378
  • Novartis$349
  • Pfizer$346
  • Novo Nordisk$323
  • Amgen$191
  • Sanofi-aventis U.S. LLC$160
  • plus $661 from 9 others

What the payments were for

  • Food & beverage$2,407100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,407 in reported general payments places this provider in the 40th percentile of 292 cardiovascular disease providers in Alabama.

See all cardiovascular disease providers in Alabama

Other cardiovascular disease in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →